OTCQB:VVCIF - Post by User
Comment by
1hot-techwomanon Sep 06, 2019 8:36am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
285 Views
Post# 30101444
RE:RE:Vivo vs Aleafia ! Same outstanding shares.... You tell me??
RE:RE:Vivo vs Aleafia ! Same outstanding shares.... You tell me??srtman03 wrote: srtman03 wrote: Aleafia does $3.9 Million in Rev's Financial Results Q2 2019 ($'000s) Q1 2019 ($'000s) Q/Q% change Gross Revenue $ 3,951 $ 1,525 159% Net Revenue(1) $ 3,839 $ 1,525 152% Sale of Cannabis Revenue $ 2,532 $ 531 377% Clinics Revenue(2) $ 1,419 $ 994 43% Gross Profit (loss) $ 2,900 $ (58) n/a Adjusted EBITDA(3) (loss) $ (2,682) $ (4,745) -43% .................................................................................................................................................................................................... Vivo does $5.3 in Rev's and has more medical Patients !! VIVO Cannabis Reports Q2 2019 Financial and Operating Results Wednesday, August 28, 2019, 7:12 PM ET VIVO Cannabis Reports Q2 2019 Financial and Operating Results -- Net revenue was $5.3 million in the quarter, a five-fold increase over the same quarter last year. -- Cultivation license was granted in the third quarter of 2019 for four new seasonal greenhouses in Napanee Ontario, increasing VIVO's annualized cultivation capacity by 4,000 kilograms and contributing to its innovative low-cost capacity plan to supply a broad line of products, including cannabis infused edibles, topicals and beverages. -- Current licensed internal cultivation capacity now totals 12,000 kilograms and agreements are in place with two licensed third-party cultivators to supply approximately 5,000 kilograms per annum. -- Health Canada approval was received to begin extraction operations using VIVO's on-site CO2 extraction system at the Napanee facility, and the Company has procured an ethanol system that will bring total extraction capacity to 50,000 kilograms per year. -- Significant progress was made on all four of VIVO's strategic priorities with capital being allocated to production, product development and international expansion -- all important initiatives that facilitate future profitable growth. ......................................................................................................................................................................................................Lots of BS games being played out here.........
Vivo at $0.41 per share and Aleafia at $1.07?? Something seriously wrong there people !!
In full agreement there ! Vivo has almost same amount of outstanding shares as Aleafia....has also more or lessa me money in the bank ...plus Vivo has more medical patients, so yes why are we at $0.44 and Aleafia at $1.05? Plus Vivo is doing lots more revenue then Aleafia. Strange indeed? Should the other way around !